Biocompatibility evaluation of hexagonal boron nitrides on healthy mouse hippocampal cell line and their positive effect on stressed cells

  1. Irem TaşkınORCID Logo,
  2. Özlem ŞenORCID Logo,
  3. Melis Emanet,
  4. Mustafa CulhaORCID Logo and
  5. Bayram Yılmaz

Submitting author affiliation: Yeditepe University, Istanbul, Turkey

Beilstein Arch. 2019, 201965. doi:10.3762/bxiv.2019.65.v1

Published 10 Jul 2019

  • Preprint

Abstract

In this study, hexagonal boron nitrides (hBNs) and their degradation product, boric acid (BA), are comparatively evaluated to investigate their biocompatibility and oxidative stress relieving effects on embryonic mouse hippocampal cell line (mHippoE-14). First, cell viability is assessed for a wide concentration range of 4.40-440 μg/mL of boron (B) containing hBNs and BA for 24 and 72 h exposures. Then, cell cycle, reactive oxygen species (ROS) generation, and cell death mechanisms are investigated at a concentration range of 4.4-44 μg/mL with increased incubation times. Finally, the influence of hBNs and BA on apoptotic body formation is monitored to analyze their nuclei integrity with confocal microscopy. Both hBNs and BA are found to be not cytotoxic at lower than 22 µg/mL B containing concentrations, and hBNs are much less cytotoxic compared to BA. At low concentration of hBNs, no detectable change in cell cycle, ROS production and DNA damage are observed. The study was further extended by exposing the cells to doxorubicin (DOX) to cause stress on cells before treating with hBNs and BA to investigate their positive effect on cellular metabolism. It is found that both hBNs and BA helps to increase the cell viability after the exposure to DOX. The results are envisioning the exploitation of hBNs as biocompatible agents for their possible biomedical applications including mitigating oxidative stress caused by various drugs used for neurological diseases and brain cancers. Since hBNs slowly degrade in biological media, they can be used as a controlled B releasing agent as compared to ionic BA in addition to their nanocarrier feature.

Keywords: Biocompatibility; boric acid; doxorubicin; hexagonal boron nitride; neuronal cells.

How to Cite

When a peer-reviewed version of this preprint is available in the Beilstein Journals, this information will be updated in the information box above. If no peer-reviewed version is available, please cite this preprint using the following information:

Taşkın, I.; Şen, Ö.; Emanet, M.; Culha, M.; Yılmaz, B. Beilstein Arch. 2019, 201965. doi:10.3762/bxiv.2019.65.v1

Download Citation
Download RIS (Reference Manager) Download BIB (BIBTEX)

© 2019 Taşkın et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the authors and source are credited.
The license is subject to the Beilstein Archives terms and conditions: (https://www.beilstein-archives.org/xiv/terms)

Other Beilstein-Institut Open Science Activities

Logo
Logo
Logo
Symposia